Ocular Therapeutix Inc
NASDAQ:OCUL

Watchlist Manager
Ocular Therapeutix Inc Logo
Ocular Therapeutix Inc
NASDAQ:OCUL
Watchlist
Price: 11.49 USD 2.41% Market Closed
Market Cap: 2.4B USD

Intrinsic Value

The intrinsic value of one OCUL stock under the Base Case scenario is 1.29 USD. Compared to the current market price of 11.49 USD, Ocular Therapeutix Inc is Overvalued by 89%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OCUL Intrinsic Value
1.29 USD
Overvaluation 89%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ocular Therapeutix Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about OCUL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is OCUL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ocular Therapeutix Inc.

Explain Valuation
Compare OCUL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OCUL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ocular Therapeutix Inc

Current Assets 387m
Cash & Short-Term Investments 344.8m
Receivables 30.8m
Other Current Assets 11.4m
Non-Current Assets 23.9m
PP&E 22.3m
Other Non-Current Assets 1.6m
Efficiency

Free Cash Flow Analysis
Ocular Therapeutix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ocular Therapeutix Inc

Revenue
55.8m USD
Cost of Revenue
-6.2m USD
Gross Profit
49.6m USD
Operating Expenses
-300.4m USD
Operating Income
-250.8m USD
Other Expenses
1.2m USD
Net Income
-249.7m USD
Fundamental Scores

OCUL Profitability Score
Profitability Due Diligence

Ocular Therapeutix Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
Declining Gross Margin
19/100
Profitability
Score

Ocular Therapeutix Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

OCUL Solvency Score
Solvency Due Diligence

Ocular Therapeutix Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
High Altman Z-Score
Low D/E
67/100
Solvency
Score

Ocular Therapeutix Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCUL Price Targets Summary
Ocular Therapeutix Inc

Wall Street analysts forecast OCUL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCUL is 21.42 USD with a low forecast of 14.14 USD and a high forecast of 32.55 USD.

Lowest
Price Target
14.14 USD
23% Upside
Average
Price Target
21.42 USD
86% Upside
Highest
Price Target
32.55 USD
183% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ocular Therapeutix Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OCUL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

OCUL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OCUL stock?

The intrinsic value of one OCUL stock under the Base Case scenario is 1.29 USD.

Is OCUL stock undervalued or overvalued?

Compared to the current market price of 11.49 USD, Ocular Therapeutix Inc is Overvalued by 89%.

Back to Top